Part, Chapter, Paragraph
1 -, 1 | and comments on specific subjects. On the other hand, integrations
2 II, 5. 1. 1| contact dermatitis, where subjects develop a delayed type of
3 II, 5. 2. 5| al, 2008). In high risk subjects, if these interventions
4 II, 5. 2. 6| 160 mg/dL in very low risk subjects) in the large majority of
5 II, 5. 2. 6| risk, especially in elderly subjects (Weijenberg MP et al, 1996).
6 II, 5. 3. 1| It is the proportion of subjects living in the population
7 II, 5. 3. 2| mortality among screened subjects and the general population.~ ~·
8 II, 5. 3. 7| lung cancer in high-risk subjects may lead to important health
9 II, 5. 4. 2| by extracting a list of subjects from databases that do not
10 II, 5. 4. 2| diabetes~ ~Prevalence of subjects with impaired glucose tolerance
11 II, 5. 4. 2| complications~ ~Percent of diabetic subjects and a HbA1c tested in last
12 II, 5. 4. 2| months~16~Percent of diabetic subjects and a HbA1c tested, with
13 II, 5. 4. 2| 14~Percent of diabetic subjects with a lipid profile in
14 II, 5. 4. 2| months~14~Percent of diabetic subjects tested in the last 12 months
15 II, 5. 4. 2| l~14~Percent of diabetic subjects tested in the last 12 months
16 II, 5. 4. 2| 13~Percent of diabetic subjects tested in the last 12 months
17 II, 5. 4. 2| 11~Percent of diabetic subjects tested in the last 12 months
18 II, 5. 4. 2| 12~Percent of diabetic subjects tested for microalbuminuria
19 II, 5. 4. 2| months~12~Percent of diabetic subjects with a tested microalbuminuria
20 II, 5. 4. 2| level~11~Percent of diabetic subjects with a tested blood pressure
21 II, 5. 4. 2| 14~Percent of of diabetic subjects with a tested blood pressure
22 II, 5. 4. 2| 90~10~Percent of diabetic subjects who are smoking~14~Percent
23 II, 5. 4. 2| smoking~14~Percent of diabetic subjects and a BMI 25 kg/m2 , 30
24 II, 5. 4. 2| complications~ ~Percent of diabetic subjects with fundus inspection in
25 II, 5. 4. 2| months~11~Percent of diabetic subjects tested in the last 12 months,
26 II, 5. 4. 2| months~6~Percent of diabetic subjects who received laser treatment<
27 II, 5. 4. 2| retinopathy~1~Percent of diabetic subjects tested serum creatinine
28 II, 5. 4. 2| months~13~Percent of diabetic subjects with ESRF serum creatinine
29 II, 5. 4. 2| the percentage of diabetic subjects that had their blood pressure
30 II, 5. 4. 2| the percentage of diabetic subjects that had their blood pressure
31 II, 5. 4. 4| of diabetes. 10% of these subjects will develop diabetes in
32 II, 5. 5.Int| anorexia nervosa in female subjects range from 0.1% to 5.7%,
33 II, 5. 5. 1| countries. Overall, 17% of the subjects interviewed presented a
34 II, 5. 6. 3| twenty-first.~ ~Most fractures in subjects aged over 50 are the result
35 II, 5. 7. 5| decided to incorporate these subjects into public health policies
36 II, 5. 7. 7| urine samples to detect subjects with microalbuminuria in
37 II, 5. 8. 3| Lindberg et al 2006). All subjects with severe COPD were symptomatic.~ ~
38 II, 5. 8. 3| present in 10.4% of the 2497 subjects with different index diseases
39 II, 5. 8. 4| During the follow-up, subjects with chronic bronchitis
40 II, 5. 8. 4| forced expiratory volume than subjects without it.~ ~In another
41 II, 5. 8. 5| involved a total of 110,355 subjects (aged 53.5±11.5 yrs; 58.
42 II, 5. 9. 2| mostly European). In stage I, subjects were given the ECRHS screening
43 II, 5. 9. 2| smaller random sample of subjects who had completed the screening
44 II, 5. 9. 3| by using data from 18,873 subjects involved in a large, nationally
45 II, 5. 9. 4| of almost all sensitized subjects in European Countries (Belgium,
46 II, 5. 9. 4| interview. In addition, in 8357 subjects, complete allergy skin and
47 II, 5. 9. 4| healthy and more sensitive subjects, such as asthmatic and allergic
48 II, 5. 9. 6| different diseases with healthy subjects, while specific questionnaires
49 II, 5. 10. 2| avoided in highly sensitised subjects. Questionnaires and sensitization
50 II, 5. 11. 3| contact dermatitis, where subjects develop a delayed type of
51 II, 5. 11. 3| 2005, the percentage of subjects living in Rome allergic
52 II, 5. 12. 3| cardiovascular conditions) in subjects with cirrhotic liver; further
53 II, 5. 12. 5| level to avoid cirrhosis.~In subjects with cirrhosis, it is possible
54 II, 5. 14. 2| year.~Numerator: Number of subjects aged 2 and over who visited
55 II, 5. 14. 2| Denominator: Total number of subjects aged 2 and over surveyed.~
56 II, 8. 2. 3| randomly selected Swedish subjects aged from 20 to 80 years (
57 II, 8. 2. 3| 2003) showed that 16.9% subjects showed no hearing impairment (
58 II, 9 | more than 85 % of older subjects spent at least 3.5 h per
59 II, 9. 3. 1| than men with diabetes. Of subjects receiving medical care for
60 II, 9. 4. 4| more than 85 % of older subjects spent at least 3.5 h per
61 II, 9. 5. 4| term disabilities are all subjects for further research. The
62 III, 10. 1. 1| expenditure increases: lean subjects demonstrate an increase
63 III, 10. 1. 1| addition, overweight and obese subjects may feel stigmatized when
64 III, 10. 2. 1| treatment outcomes and other subjects could benefit from future
65 III, 10. 2. 1| severity and extent in young subjects increases with age, beginning
66 III, 10. 2. 1| methodology and age range of the subjects. The annual change in the
67 III, 10. 2. 1| Survey name~Acronym~Year~Subjects (number)~Age range~Method~
68 III, 10. 2. 1| Europe. It includes 35,955 subjects (22,924 women and 13,031
69 III, 10. 2. 1| more than half (56%) of the subjects with very low levels (<3
70 III, 10. 2. 1| indeed been shown for these subjects compared to omnivores. Considering
71 III, 10. 2. 1| Austria, and by younger subjects. However, in people over
72 III, 10. 2. 1| frequent in hospitalized subjects. A low status was also found
73 III, 10. 2. 2| 160 mg/dL in very low risk subjects) in the large majority of
74 III, 10. 2. 3| risk, especially in elderly subjects. A reduction of blood pressure
75 III, 10. 4. 2| areas, for which the main subjects are:~ ~Qualified presumption
76 III, 10. 5. 2| future reports on similar subjects (Eurofound, Institute of
77 IV, 12. 2 | protein, fibers. In high risk subjects, if these interventions
78 IV, 12. 10 | references to bioethical subjects see e. g. Federal Ministry
79 IV, 13. 7. 5| informed consent from the data subjects. However, in a public health
80 IV, 13. 7. 5| explicit consent from all data subjects. However, the Article 29
